SurgiVance, a Leading Healthcare Innovator, Announced Today That Michael Li, PhD Has Been Appointed Chief Executive Officer

Date:

SurgiVance, a leading innovator in developing AI-driven, direct-to-digital confocal pathology, announced today that Michael Li, PhD has been appointed Chief Executive Officer.

NEW YORK - January 9, 2023 - (Newswire.com)

"On behalf of the Board, we are very pleased to welcome Dr. Li to SurgiVance as the company is moving into a new phase of product development and commercialization, and to further its leadership position in advancing and innovating healthcare with the next generation direct-to-digital confocal pathology," said Dr.  Gareau, the founder and Chairman of Board at SurgiVance. "We are delighted that Dr. Li can join the SurgiVance team, and excited to have him as a partner on our journey. He is not only an experienced technology executive, but also a great strategic navigator, which is key in this exciting and rapidly evolving field."

Dr. Li brings with him many years of rich leadership experience in medical devices, healthcare, and technology, from R&D, to new product commercialization, to general management. He has held senior management positions in major multinationals such as Siemens Medical, as well as numerous medical device and IVD startups such as Neural Analytics. Dr. Li received his doctoral degree in physics from the University of Washington, Seattle.

"I am impressed by the technology advancement and significant innovations by Dr. Gareau and the SurgiVance team and I am excited to lead the team in moving the technology to market. Pathology is a corner stone of medical care. Hopefully, we will ease the existing true pain points experienced by physicians, improve patient care, and save more lives." said Dr. Li.


Contact Information:
Michael Li
Chief Executive Officer
[email protected]
802-448-2623

Daniel Gareau
President
[email protected]
802-448-2623
Related Files
SurgiVance_Tech.pdf



Press Release Service by Newswire.com

Original Source: SurgiVance, a Leading Healthcare Innovator, Announced Today That Michael Li, PhD Has Been Appointed Chief Executive Officer

Related articles

Drake Bell opens up about experiencing sexual assault at Nickelodeon

The star of Drake & Josh will be a featured guest on the docuseries Quiet on Set, which...

Brent Floating Farms Announces the Opportunity to Join Their Sustainability Revolution

The revolutionary team at Brent Floating Farms aims to raise $20 Million via Reg D 506(c) Brent Floating Farms Cargo Ships Concept image of the B...

John Williamson Promoted to Principal, SNH Capital Partners

AUSTIN, Texas, March 27, 2024 (Newswire.com) - SNH Capital Partners ("SNH"), a leading U.S.-based private investment firm focused on long-term partnerships, i...

InStride Health Raises Oversubscribed $30 Million Series B to Expand Access to Best-in-Class Specialty Treatment for Pediatric Anxiety and OCD

General Catalyst leads funding round joined by .406 Ventures, Valtruis, Mass General Brigham Ventures, and Hopelab Foundation to bolster insurance-based mental health program availability in new markets ...